Cytidine-5-carboxamide modified nucleotide compositions and methods related thereto
US10239908B2 · kind B2 · utility
10Cited by
46References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 7, 2018 |
| Grant date | Mar 26, 2019 |
| Priority date | — |
| Expiry date | Mar 7, 2038 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/55
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Described herein are 5-position modified cytosine nucleotides and nucleosides as well as phosphoramidites and triphosphates derivatives thereof. Further provided are methods of making and using the same, and compositions and uses of the modified nucleosides as part of a nucleic acid molecule (e.g., aptamer).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.